unknown
Stage
1
Investors
About
Bioptamers develops personalized precision cancer therapies through a microfluidic platform that selects synthetic aptamer molecules designed to specifically target cancer cells and deliver therapeutic interventions.
Explore Bioptamers's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.